• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Saturday 07/21/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

AHAR Pharma

  • 8:44 AM

    ORLANDO, Fla., Feb. 20, 2018 (GLOBE NEWSWIRE) — via OTC PR WIRE– Immune Therapeutics, Inc. (OTCQB:IMUN) (“Immune” “IMUN” or the “Company”), a clinical late stage biopharmaceutical company focused on the development of two immunomodulating therapies (IRT-103 “Lodonal” and IRT-101 “MENK”) for the treatment of autoimmune diseases, inflammatory diseases, cancer and HIV/AIDs,  today announced the company has shipped its initial order of Lodonal to AHAR Pharma in Nigeria.  In addition, IMUN has received both trademark and patent approval from the Federal

    Read more
  • 2:29 PM

    NEW YORK, Oct. 2, 2015, NASDAQ, NEWT, /PRNewswire/ — Newtek Business Services Corp., (NASDAQ: NEWT) (www.thesba.com) The Small Business Authority®, with a portfolio of over 100,000 business accounts, announced today the findings of its SB Authority Market Sentiment Survey, a monthly window into the concerns of independent business owners. Based on a poll of over 1,300 respondents, the key finding from the September survey is 96% of business owners have not been denied access to a traditional bank loan. Additionally, 91%

    Read more
  • 3:18 PM

    NEW YORK, June 24, 2015 /PRNewswire/ — Newtek Business Services Corp. (“The Company”), (NASDAQ: NEWT), an internally managed business development company (“BDC”), today announced that The U.S. Small Business Administration approved the restructure of Newtek Small Business Finance, LLC’s $50 million revolving line of credit with Capital One, North America.  As a result, the revolving line of credit now has a holding-company-only guarantee, and is no longer collateralized by The Company’s portfolio companies.  In addition, the term of the loan was

    Read more
Public Wire Banner